US FDA ‘Project Post COVIDity’ Will Track Infection Impact On Cancer Patients Using Real-World Data

Oncology Center of Excellence program will use the Evidence Accelerator to examine COVID’s impact on treatment initiation, regimen selection and therapeutic utilization, potential adverse sequalae, and outcomes.

shutterstock 52899094  Walking crab
Tracking the impact of COVID infections on cancer patients using real-world data is among the new projects launched by the US FDA’s Oncology Center of Excellence. • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials